{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:13Z","timestamp":1772166253248,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02948-8","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:36:33Z","timestamp":1761741393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing steroid treatment for UC patients with CMV colitis: a multicenter real-world study"],"prefix":"10.1186","volume":"22","author":[{"given":"Haozheng","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linglin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gechong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"4","key":"2948_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s11894-012-0266-4","volume":"14","author":"DM You","year":"2012","unstructured":"You DM, Johnson MD. Cytomegalovirus infection and the gastrointestinal tract. Curr Gastroenterol Rep. 2012;14(4):334\u201342.","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"2948_CR2","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3748\/wjg.v22.i6.2030","volume":"22","author":"S Pillet","year":"2016","unstructured":"Pillet S, Pozzetto B, Roblin X. Cytomegalovirus and ulcerative colitis: place of antiviral therapy. World J Gastroenterol. 2016;22(6):2030\u201345.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2948_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144\u201364.","journal-title":"J Crohns Colitis"},{"issue":"12","key":"2948_CR4","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1111\/j.1572-0241.2006.00869.x","volume":"101","author":"A Kandiel","year":"2006","unstructured":"Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006;101(12):2857\u201365.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"2948_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/00365521.2019.1646798","volume":"54","author":"SJ Oh","year":"2019","unstructured":"Oh SJ, Lee CK, Kim YW, Jeong SJ, Park YM, Oh CH, et al. True cytomegalovirus colitis is a poor prognostic indicator in patients with ulcerative colitis flares: the 10-year experience of an academic referral inflammatory bowel disease center. Scand J Gastroenterol. 2019;54(8):976\u201383.","journal-title":"Scand J Gastroenterol"},{"key":"2948_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2147\/IDR.S149784","volume":"10","author":"YL Lv","year":"2017","unstructured":"Lv YL, Han FF, Jia YJ, Wan ZR, Gong LL, Liu H, et al. Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis. Infect Drug Resist. 2017;10:511\u20139.","journal-title":"Infect Drug Resist"},{"issue":"Suppl 2","key":"2948_CR7","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1093\/ibd\/izab358","volume":"28","author":"H Yang","year":"2022","unstructured":"Yang H, Qian J. Current status of cytomegalovirus colitis among patients with inflammatory bowel disease in China: a questionnaire-based multicenter study. Inflamm Bowel Dis. 2022;28(Suppl 2):S45-51.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"2948_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00384-018-3210-8","volume":"34","author":"W Schenk","year":"2019","unstructured":"Schenk W, Klugmann T, Borkenhagen A, Klecker C, Dietel P, Kirschner R, et al. The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic. Int J Colorectal Dis. 2019;34(3):393\u2013400.","journal-title":"Int J Colorectal Dis"},{"key":"2948_CR9","doi-asserted-by":"crossref","unstructured":"Shukla T, Singh S, Loftus EV Jr., Bruining DH, McCurdy JD. Antiviral therapy in steroid-refractory ulcerative colitis with cytomegalovirus: systematic review and meta-analysis. Inflamm Bowel Dis. 2015;21(11):2718\u201325.","DOI":"10.1097\/MIB.0000000000000489"},{"key":"2948_CR10","doi-asserted-by":"crossref","unstructured":"Jones A, McCurdy JD, Loftus EV Jr., Bruining DH, Enders FT, Killian JM, et al. Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus. Clin Gastroenterol Hepatol. 2015;13(5):949\u201355.","DOI":"10.1016\/j.cgh.2014.09.042"},{"issue":"9","key":"2948_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183951","volume":"12","author":"K Okahara","year":"2017","unstructured":"Okahara K, Nagata N, Shimada T, Joya A, Hayashida T, Gatanaga H, et al. Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis. PLoS ONE. 2017;12(9):e0183951.","journal-title":"PLoS ONE"},{"issue":"4","key":"2948_CR12","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1097\/MCG.0000000000000759","volume":"52","author":"Y Wang","year":"2018","unstructured":"Wang Y, Aggarwal P, Liu X, Lu H, Lian L, Wu X, et al. Antiviral treatment for colonic cytomegalovirus infection in ulcerative colitis patients significantly improved their surgery free survival. J Clin Gastroenterol. 2018;52(4):e27\u201331.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"2948_CR13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/MIB.0000000000001095","volume":"23","author":"H Yang","year":"2017","unstructured":"Yang H, Zhou W, Lv H, Wu D, Feng Y, Shu H, et al. The association between CMV viremia or endoscopic features and histopathological characteristics of CMV colitis in patients with underlying ulcerative colitis. Inflamm Bowel Dis. 2017;23(5):814\u201321.","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 3","key":"2948_CR14","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1\u2013106.","journal-title":"Gut"},{"issue":"6","key":"2948_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","volume":"15","author":"T Kucharzik","year":"2021","unstructured":"Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, et al. Ecco guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021;15(6):879\u2013913.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"2948_CR16","first-page":"217","volume":"37","author":"Inflammatory Bowel Disease Group CSoDD, Chinese Medical Association","year":"2017","unstructured":"Inflammatory Bowel Disease Group CSoDD, Chinese Medical Association. Chinese evidence-based consensus on opportunistic infections in inflammatory bowel disease. Chin J Digestion. 2017;37(4):217\u201326.","journal-title":"Chin J Digestion"},{"issue":"2","key":"2948_CR17","first-page":"73","volume":"44","author":"Inflammatory Bowel Disease Group of Chinese Society of Gastroenterology of Chinese Medical Association IBDQCCoC","year":"2024","unstructured":"Inflammatory Bowel Disease Group of Chinese Society of Gastroenterology of Chinese Medical Association IBDQCCoC. Chinese clinical practice guideline on the management of ulcerative colitis(2023, Xi\u2032an). Chin J Dig. 2024;44(2):73\u201399.","journal-title":"Chin J Dig"},{"issue":"10","key":"2948_CR18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","volume":"6","author":"A Dignass","year":"2012","unstructured":"Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6(10):965\u201390.","journal-title":"J Crohns Colitis"},{"issue":"12","key":"2948_CR19","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","volume":"14","author":"JD Lewis","year":"2008","unstructured":"Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14(12):1660\u20136.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"2948_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","volume":"8","author":"JF Rahier","year":"2014","unstructured":"Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8(6):443\u201368.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"2948_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/00365521.2021.2006298","volume":"57","author":"M Zhang","year":"2022","unstructured":"Zhang M, Bai X, Zhang H, You Y, Lv H, Li Y, et al. The role of cytomegalovirus colitis on short- and long-term outcomes for patients with ulcerative colitis. Scand J Gastroenterol. 2022;57(3):282\u20139.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"2948_CR22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/ibd\/izy045","volume":"24","author":"J Johnson","year":"2018","unstructured":"Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson K. CMV disease in IBD: comparison of diagnostic tests and correlation with disease outcome. Inflamm Bowel Dis. 2018;24(7):1539\u201346.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2948_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/apt.13234","volume":"42","author":"R Ciccocioppo","year":"2015","unstructured":"Ciccocioppo R. Letter: cytomegalovirus infection in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42(1):127\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2948_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3904\/kjim.2017.087","volume":"32","author":"SC Park","year":"2017","unstructured":"Park SC, Jeen YM, Jeen YT. Approach to cytomegalovirus infections in patients with ulcerative colitis. Korean J Intern Med. 2017;32(3):383\u201392.","journal-title":"Korean J Intern Med"},{"issue":"11","key":"2948_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01159-24","volume":"12","author":"L Melotti","year":"2024","unstructured":"Melotti L, Rinaldi M, Salice M, Dussias NK, Vanigli N, Calabrese C, et al. Is CMV dnaemia an early marker of CMV colitis in patients with active ulcerative colitis? Microbiol Spectr. 2024;12(11):e0115924.","journal-title":"Microbiol Spectr"},{"issue":"9","key":"2948_CR26","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/MIB.0000000000001160","volume":"23","author":"U Kopylov","year":"2017","unstructured":"Kopylov U, Papamichael K, Katsanos K, Waterman M, Bar-Gil Shitrit A, Boysen T, et al. Impact of Infliximab and cyclosporine on the risk of colectomy in hospitalized patients with ulcerative colitis complicated by Cytomegalovirus-a multicenter retrospective study. Inflamm Bowel Dis. 2017;23(9):1605\u201313.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02948-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:36:36Z","timestamp":1761741396000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02948-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2948"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02948-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6921587\/v1","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Peking Union Medical College Hospital (approval number: I-23PJ1345). Due to the retrospective nature of the study and the use of anonymized clinical data, the IRB granted a waiver of informed consent in accordance with local regulations and the Helsinki Declaration (2013 Update).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (no identifiable patient data are included in this study).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"349"}}